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Strengths and limitations of this study
 ► This review is the first to comprehensively sum-
marise the various prognostic models that have 
been produced to identify complications, severity 
and risk of mortality in patients with severe malaria.
 ► The review covers prognostic models produced 
worldwide and for all the various malaria species.
 ► The review reduced the risk of bias by using an in-
dependent review process for the screening of po-
tential articles and the extraction of data.
 ► Considering the wide variety of statistical methods 
used to generate and validate these models, there 
is the risk of heterogeneity in interpretation of the 
results.
 ► The search was carried out in only one language 
which could potentially exclude some relevant stud-
ies published in different languages.
AbStrACt
Objective Malaria infection could result in severe 
disease with high mortality. Prognostic models and scores 
predicting severity of infection, complications and mortality 
could help clinicians prioritise patients. We conducted a 
systematic review to assess the various models that have 
been produced to predict disease severity and mortality in 
patients infected with malaria.
Design A systematic review.
Data sources Medline, Global health and CINAHL were 
searched up to 4 September 2019.
Eligibility criteria for selecting studies Published 
articles on models which used at least two points (or 
variables) of patient data to predict disease severity; 
potential development of complications (including coma 
or cerebral malaria; shock; acidosis; severe anaemia; 
acute kidney injury; hypoglycaemia; respiratory failure 
and sepsis) and mortality in patients with malaria 
infection.
Data extraction and synthesis Two independent 
reviewers extracted the data and assessed risk of bias 
using the Prediction model Risk Of Bias Assessment Tool.
results A total of 564 articles were screened and 24 
articles were retained which described 27 models/
scores of interests. Two of the articles described models 
predicting complications of malaria (severe anaemia in 
children and development of sepsis); 15 articles described 
original models predicting mortality in severe malaria; 3 
articles described models predicting mortality in different 
contexts but adapted and validated to predict mortality 
in malaria; and 4 articles described models predicting 
severity of the disease. For the models predicting mortality, 
all the models had neurological dysfunction as a predictor; 
in children, half of the models contained hypoglycaemia 
and respiratory failure as a predictor meanwhile, six out 
of the nine models in adults had respiratory failure as a 
clinical predictor. Acidosis, renal failure and shock were 
also common predictors of mortality. Eighteen of the 
articles described models that could be applicable in real- 
life settings and all the articles had a high risk of bias due 
to lack of use of consistent and up- to- date methods of 
internal validation.
Conclusion Evidence is lacking on the generalisability 
of most of these models due lack of external validation. 
Emphasis should be placed on external validation of 
existing models and publication of the findings of their 
use in clinical settings to guide clinicians on management 
options depending on the priorities of their patients.
PrOSPErO registration number CRD42019130673.
IntrODuCtIOn
Malaria is a disease caused by infection with a 
protozoan parasite of the genus Plasmodium. 
The most relevant of these species is Plasmo-
dium falciparum as it causes most deaths from 
the disease.1 Another species of relevance 
is Plasmodium vivax which is predominantly 
found in Asia and has a wider distribution.2 
Malaria infection can result in severe disease 
and is associated with a high mortality. In 
about 108 countries where the transmis-
sion of the disease still occurs, an estimated 
435 000 people died in 2017.3 4
The incidence of malaria cases has 
decreased by 41% worldwide in the last 
10 years, with about 17 countries in Latin 
America and the Middle East reporting no 
new cases of malaria over this period.3 5 There 
are, however, concerns that the fight against 
malaria might be slowed down by an overem-
phasis on prevention over treatment.6
Treatment and clinical management of 
malaria is made difficult due to potential 
evolution of simple infections into life- 
threatening severe disease; the multiorgan 
affection of severe disease; the dilemma of 
when to admit to intensive care units (ICUs) 
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considering limited resources and the occurrence of 
concomitant sepsis infection with malaria.7 8 Some of 
these issues can be addressed with the help of guidelines; 
scores or models that could help clinicians predict the 
occurrence of severe disease and complications in order 
to act appropriately.
We therefore conducted this review to systematically 
assess the various predictive models or scores available 
to guide clinicians in the management of severe malaria, 
whether these models have been validated and if there is 
any evidence that they are being successfully used in the 
clinical setting.
MEthODS
Institutional review board approval and informed consent 
were not required for this systematic review. We reported 
our findings according to Preferred Reporting Items for 
Systematic Reviews and Meta- Analysis guidelines (online 
supplementary appendix 1).
Search strategy and selection criteria
We searched MEDLINE, CINAHL and Global Health 
databases using a tailored search strategy (online supple-
mentary appendix 2) to identify all the relevant titles and 
abstracts of studies (randomised control trials, cohort, 
cross- sectional and case–control studies) published 
in English from inception of the database up to the 4 
September 2019, that reported predictive/prognostic 
scores or models that could be used in the management 
of malaria. These included:
1. Scores/models that predicted the severity of disease 
as this could guide clinicians’ decisions to admit for 
intensive care management or the use of parenteral 
treatment.
2. Scores/models that predicted the potential develop-
ment of complications (including coma or cerebral 
malaria; shock; acidosis; severe anaemia; acute kidney 
injury; hypoglycaemia; respiratory failure and sepsis).
3. Scores/models that predicted mortality in patients 
with malaria infection.
The main keywords in the search strategy included: 
‘prognostic model/score’, ‘predictive model/score’ and 
‘predictive value of tests’ coupled with ‘malaria’, ‘plas-
modium’, ‘anti- malarials’, ‘malaria falciparum’, ‘malaria 
vivax’ and ‘clinical malaria’. We further canvassed the 
references of eligible papers to identify similar papers for 
review.
We excluded any duplicate studies, editorials, system-
atic reviews, case studies, conference abstracts, unpub-
lished studies and expert commentaries. For studies with 
more than one publication of findings, we selected the 
most recent publication.
We also excluded studies which contained models or 
scores that were aimed at the diagnosis of malaria as we 
intend to limit the scope of the review to only models 
that could be used to predict severity, mortality or risk 
of complications—that could guide clinicians in their 
management options. Studies that used animal models to 
predict disease severity were also excluded.
Two independent reviewers (TN and BST) screened 
the titles and abstracts for compliance to the aforemen-
tioned inclusion and exclusion criteria and any conflicts 
were settled by mutual agreement. Articles considered to 
have data relevant to the topic were assessed in detail and 
the references cited in these publications were searched 
to identify further publications.
Data extraction
Data extraction sheets which were prepared prior to 
screening were used by the two independent reviewers to 
obtain the following details for inclusion into the final 
review: last name of first author; date of publication; 
period of patient recruitment and/or follow- up; country 
of study; sample size; age group; type of predictive model; 
name of model; method of internal validation (calibra-
tion and discrimination); diagnostic properties of model 
and evidence of external validation or use in clinical 
settings.
Definitions
By prognostic/predictive model, we mean a statistical 
tool which uses at least two points (or variables) of patient 
data to predict a specific clinical outcome.9 Prognostic 
models applied in clinical settings are usually used at the 
discretion of physicians for accurate future predictions 
based on characteristics gathered in the present.9 10 The 
information found in prognostic models is usually specific 
to the patients’ characteristics rather than the disease or 
treatment and includes: prediction of chance or the dura-
tion of survival; classification of patients into risk groups; 
and prediction of clinical events related to the treatment 
the patient is receiving.11
For models that used the area under the curve (AUC) 
or c- statistic to assess discrimination, the following clas-
sification was used: 0.90–1—excellent; 0.80–0.90—good; 
0.70–0.80—fair; 0.60–0.70—poor and 0.50–0.60—very 
poor discriminative properties.12
Data synthesis and analysis
We assessed and discussed the selected studies qualita-
tively to describe the diagnostic properties of the models 
proposed in the study, their intended purpose and 
evidence of use of the model in other clinical settings.
We further divided the models into various categories: 
models used to predict a potential complication of severe 
malaria; models used to predict mortality as an outcome 
and models used to predict severity of malaria infection.
Assessment of risk of bias and applicability
The risk of bias and applicability of the models in the 
various studies were assessed by the two independent 
reviewers using the Prediction model Risk Of Bias Assess-
ment Tool (PROBAST)13 14 (online supplementary 
appendix 3). Any disagreements were handled by mutual 
agreement.
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Figure 1 Flowchart showing reasons for exclusion of various studies from the review.
Patient and public involvement
Patients and the public were not involved in the design 
and conduction of this review.
rESultS
A total of 564 articles were identified by the electronic 
search of the databases. The titles and abstracts of these 
articles were screened to retain 59 articles for full text 
review. These were then evaluated according to the inclu-
sion criteria and 24 articles were identified describing 27 
models/scores of interests; after eliminating 23 irrelevant 
articles, 9 articles which used only one variable to predict 
an outcome and two articles describing models in other 
languages (figure 1).
Two of the articles described models predicting compli-
cations of malaria8 15; 15 described original models 
predicting mortality in severe malaria16–30; 3 described 
models predicting mortality in different contexts but 
adapted and validated to predict mortality in malaria31–33; 
and 4 articles described models predicting severity of the 
disease.34–37 One of the articles described three models 
to predict mortality paediatric severe malaria,31 while 
another described two models to predict mortality in 
adult severe malaria.24 The rest of the articles described 
one model each.
Using the PROBAST to assess risk of bias and appli-
cability, none of the studies had a low risk of bias while 
six studies were not found to be applicable in real- life 
settings15 16 22 34–36 (online supplementary appendix 3).
The general characteristics of the studies included in 
the review are summarised in tables 1–4.
Models predicting the risk of complications in malaria 
infection
Webber et al15 in 1997 conducted a study to predict the risk 
of severe anaemia (packed cell volume <15%) in children 
with severe malaria in the Gambia using logistic regres-
sion analysis. This model was not internally validated, and 
the two predictors identified were pallor of the conjunc-
tiva and pallor of the palms. There is no evidence from 
this review that the model has been externally validated 
and is being used in clinical settings.
In 2018, Njim et al8 described a prognostic model for 
clinical use to predict the risk of sepsis development 
among adult patients (>16 years old) admitted for severe 
falciparum malaria in Southeast Asia. They used data 
from South East Asian Quinine Artesunate Malaria Trial 
(SEQUAMAT)—a large randomised control trial (RCT) 
conducted to determine the benefits of intravenous arte-
sunate over quinine treatment for severe malaria. They 
used a multivariable logistic regression approach with 
internal validation using bootstrapping to generate a 
prognostic model with modest discriminative abilities 
(AUC: 0.789) containing the following predictive vari-
ables: female sex, high blood urea nitrogen, high plasma 
anion gap, respiratory distress, shock on admission, high 
parasitaemia, coma and jaundice. The model has not 
been externally validated and there is no evidence of use 
in clinical settings.
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Models predicting mortality in severe malaria
 Models predicting mortality in paediatric severe malaria
Ten articles described models that predicted mortality in 
paediatric severe malaria.16 20–23 27 28 30–32 Three articles 
described models which predicted mortality in paediatric 
patients with cerebral malaria16 21 27; two articles described 
models generated to assess mortality in different condi-
tions that were validated for use in the present studies31 32; 
and five articles described original models predicting the 
risk of mortality in children with severe malaria.20 22 23 28 30
 Models predicting mortality in paediatric cerebral malaria
Molyneux et al27 in 1989 conducted a study among 131 
comatose Malawian children with severe cerebral malaria 
to determine the prognostic factors for death in these 
patients. The authors derived a ‘bedside prognostic 
index’ with: blood glucose ≤2.2 mmol/L; parasitaemia 
>106 ring forms/μL; white blood cell count >15×10/L; 
age ≤3 years; coma score (modification of the Glasgow 
coma score)=0; absent corneal reflexes; signs of decere-
bration and convulsions; as predictors of mortality with 
each predictor assigned a score of 1. Individuals with a 
score ≥4 were more likely to die. This score was calculated 
only using univariable analysis and internal and external 
validation were not done.
In 1997 in Gambia, Jaffar et al21 performed a retrospec-
tive analysis on data obtained from a randomised control 
trial during which artemether was compared with quinine 
and a monoclonal antibody against tumour necrosis 
factor (TNF) compared with a placebo in patients with 
cerebral malaria. They used these data to identify predic-
tors of mortality in cerebral malaria using a multivariable 
logistic regression model. A cold periphery, a coma score 
of either 0 or 1 (assessed using the Blantyre coma scale 
measured on a scale of 0–5), and hypoglycaemia were 
found to be present at admission in 90% of the children 
who died. This model was not internally validated.
Conroy et al16 in 2012 conducted a study among 155 
children aged 8 months—14 years in Malawi to determine 
predictors of mortality in cerebral malaria. They used a 
multivariable logistic regression model containing clin-
ical parameters and biomarkers with a modest discrimi-
native ability (C- index of 0.79) after internal validation; 
which contained the following variables: age, Blantyre 
coma score, respiratory distress, severe anaemia, angio-
poietin-1, angiopoietin-2 and sTie-2 levels. The model was 
not externally validated.
 Original models predicting mortality in paediatric severe malaria
Krishna et al22 in 1994 conducted a study in the Gambia to 
predict mortality in children aged 8 months to 14 years. 
They used a multivariable logistic regression model inter-
nally validated using the Wald statistic to determine that 
the coma score (using the Blantyre coma scale), whole 
blood lactate/glucose ratio and TNF level were the best 
predictors of death.
In 1995, Marsh et al23 studied 1844 children in Kenya 
to determine predictors of life- threatening malaria (risk 
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d
of death) using a multivariable logistic regression model. 
They determined that impaired consciousness (assessed 
using the Blantyre coma scale), hypoglycaemia, respira-
tory distress and jaundice could correctly predict 84.4% 
of deaths in the sample population. The model was not 
validated internally or externally.
In 2005, Newton et al28 conducted a study to assess 
the prognostic value of measures of acid/base balance 
in paediatric falciparum malaria. They examined 14 605 
children in Malawi (Blantyre), Kenya (Kilifi) and Ghana 
(Kumasi); where they determined that deep breathing, 
Blantyre Coma Score, inability to sit, and weight- for- age Z 
score were independent predictors of mortality in all the 
three sites. Discrimination of the model was performed 
by calculating the area under the receiver operating curve 
(AUROC). After addition of laboratory data to these 
models—hypoglycaemia, base excess and lactate concen-
trations; the c- statistics obtained were 0.88 (Blantyre), 
0.87 (Kilifi) and 0.83 (Kumasi) denoting good discrimi-
native properties of the models.
Helbok et al20 in 2009 produced the the Lambarene 
Organ Dysfunction Score (LODS) which combined 
three variables: coma, prostration and deep breathing 
to generate a model using multivariable logistic regres-
sion which predicted death in African children—Banjul 
(Gambia), Blantyre (Malawi), Kilifi (Kenya), Kumasi 
(Ghana), and Lambarene and Libreville (Gabon); who 
were admitted for severe falciparum malaria. Each 
component of the model was assigned a score of 1 and 
a LODS of 3 at admission had a 98% specificity and 25% 
sensitivity in predicting death. Meanwhile a LODS ≥1 had 
a sensitivity of 85% and a specificity of 63%. The model 
had good discriminative properties with an AUC of 0.80 
(95% CI 0.79 to 0.82). In 2015, Conroy et al31 externally 
validated this model among 1589 Ugandan children. The 
model showed good discriminative properties with an 
AUC of 0.898.
Similarly, in 2012, von Seidlein et al30 conducted 
an analysis of data from an RCT carried out in several 
African countries (Gambia, Mozambique, Nigeria, 
Rwanda, Kenya, DRC, Tanzania, Ghana and Uganda) to 
generate a model for predicting mortality from severe 
falciparum malaria using multivariable logistic regression 
analysis and internally validated by AUROC analysis. After 
analysis of data from 5426 children, base deficit, impaired 
consciousness (assessed using the Blantyre Coma Score), 
convulsions, elevated blood urea and underlying chronic 
illness were identified in the model to predict mortality 
with a good discriminative ability—AUROC: 0.85 (95% 
CI 0.83 to 0.87).
 Existing models validated for use in the prediction of mortality in 
severe malaria in children
As described above, Conroy et al31 externally validated 
the LODS model among 1589 Ugandan children. The 
authors further externally validated two other scores: 
the Signs of Inflammation in Children that Kill (SICK) 
score which was developed in India as a practical triage 
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tool using variables related to the systemic inflammatory 
response syndrome, with data collected from 1099 chil-
dren in 2003 admitted for any paediatric illness38; and 
the Paediatric Early Death Index for Africa (PEDIA) 
score which was developed to predict early death among 
8091 children in Kenya in 2003 admitted for paedi-
atric illnesses.39 The original SICK score containing the 
following variables: altered consciousness, temperature, 
heart rate, respiratory rate, systolic blood pressure, capil-
lary refill time and age; had good discriminative proper-
ties with an AUC of 0.887.38 Externally validated against 
this cohort of 1589 children, the score maintained its 
good discriminative properties with an AUC of 0.846. 
Similarly, the PEDIA score which originally had excellent 
discriminative properties with an AUC of 0.9339 had good 
discriminative properties (AUC: 0.896) when externally 
validated on the cohort of 1589 Ugandan children.31 The 
original PEDIA score contained Kwashiorkor, jaundice, 
subcostal indrawing, prostration (±seizures) and wasting 
as variables in the model. However, kwashiorkor was not 
included in the validation model as it was not measured 
among the Ugandan children.
In 2006, Gerardin et al32 externally validated the Paedi-
atric Risk of Mortality (PRISM) model which was origi-
nally developed in 1988 by Pollack et al40 to reduce the 
number of physiological variables required for paediatric 
ICU death risk assessment. The model was developed 
from data of 1227 patients with 105 deaths and contained 
14 variables: systolic blood pressure, temperature, mental 
status, heart rate, dilatation of pupils, pH, total CO2, PCO2, 
arterial PaO2, serum glucose, potassium, urea, creatinine, 
white blood cells, prothrombin time and platelet count. 
The original score had excellent discriminative proper-
ties with an AUC of 0.92.40 Gerardin et al used a cohort of 
311 Senegalese children admitted with severe malaria to 
externally validate this model. The model showed good 
discriminative properties in predicting death in children 
with severe malaria—AUC: 0.86 (95% CI 0.81 to 0.90).32
Models predicting mortality in adult severe malaria
There were eight articles assessing models that predicted 
mortality in adult severe malaria.17–19 24–26 28 41
In 1995, Wilairatana et al41 used the APACHE II score 
(the acute physiology and chronic health evaluation 
system score commonly used in ICUs) based on 12 
physiological variables—mean arterial pressure (MAP), 
temperature, heart rate, respiratory rate, arterial pH, 
PaO2, haematocrit, white blood cells (WBC) count, creat-
inine, sodium, potassium and Glasgow coma score to 
predict the risk of mortality in adult patients with cere-
bral malaria in Thailand. The score was able to predict 
mortality with a 95.8% accuracy. The original APACHE II 
model was produced in 1985 by Knaus et al,42 and clinical 
judgement and physiological relationships were used to 
assign weightings for the various factors in the model.
Dondorp et al17 in 2004 created a model using logistic 
regression with laboratory data form 268 patients in 
Vietnam to determine the risk of mortality in adult 
patients with severe malaria. This model had a good 
discriminative value with an AUROC of 0.81. The labo-
ratory variables asscoicated with mortality in this cohort 
were: plasma lactate, plasma creatinine and a strong anion 
gap. On the other hand, in 2007, Mishra et al24 created 
the malaria score for adults (MSA) and the malaria 
prediction score (MPS) from a cohort of 212 patients 
in India to predict mortality in severe malaria. The MSA 
was an upgrade of the malaria prognostic index (MPI) 
which required laboratory data and included a small 
proportion of children. The clinical variables included 
in the MSA were: severe anaemia, acute renal failure, 
respiratory distress and cerebral malaria and had a sensi-
tivity of 89.9% and a specificity of 70.6%. This model was 
externally validated by Santos et al43 among 59 patients 
with imported severe malaria in Portugal and was shown 
to have good discriminative properties—AUROC: 0.84; 
95% CI 0.70 to 0.98.
Similarly, Hanson et al18 produced the coma acidosis 
malaria (CAM) score after using a logistic regres-
sion analysis on data previously collected from the 
SEQUAMAT. The authors proposed the use of the pres-
ence of a coma and base deficit to calculate a five- point 
score to predict mortality. The score had good discrim-
inative properties with an AUROC of 0.81 (95% CI 
0.77 to 0.84). The same author used data from several 
cohort studies and RCTs carried out in Bangladesh, 
India, Indonesia, Vietnam and Myanmar to predict 
48 hours survival and survival to discharge in patients 
with severe malaria.19 The model containing the vari-
ables: shock, oligoanuria, dysglycaemia, respiratory 
rate, Glasgow coma score and fever could correctly 
predict 48- hour survival in 99.4% of the patients and 
survival to discharge in 96.9% of patients.
Mohapatra et al26 in 2009 carried out a cohort study of 
2089 patients in 2009, where they produced the malaria 
severity score (MSS) to predict mortality in adult patients 
with severe falciparum malaria in India. They assessed 
seven organ systems: neurological, renal, haematological, 
hepatic, respiratory, cardiovascular and metabolic organ 
systems; assigning a maximum score of 0–3 for each organ 
system. The model had excellent discriminative proper-
tiens with an AUROC of 0.9. The authors also developed 
the GCRBS (Glasgow coma scale, creatinine, respiratory 
rate, bilirubin and systolic BP) score in 2014 as an alter-
native to other scores like the APACHE II score which 
was considered cumbersome.25 The score had a sensitivity 
of 85.3% and a specificity of 95.6% in predicting a fatal 
outcome in severe malaria.
In 2013 in Thailand, Newton et al29 conducted a retro-
spective analysis of 988 records with severe falciparum 
malaria to produce the MPI validated using ROC curve 
analysis and internal validation by data splitting. The MPI 
contained the following variables: Glasgow coma scale, 
parasitaemia, plasma lactate, serum bilirubin, pigmented 
parasites and treatment with ACT and had excellent 
discriminative properties with an AUROC of 0.97.
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Models predicting the severity of malaria
The multiorgan dysfunction score (MODS) which is 
an index used in severely ill patients admitted in ICUs 
to determine the severity of their disease irrespective of 
the diagnosis.34 44 The score evaluates ten organ systems: 
heart, blood vessel, blood, respiratory system, metabo-
lism, gastrointestinal system, liver, kidney and urinary 
tract, immune system and central nervous system—giving 
a score of 1–5 for each system depending on the level 
of dysfunction of the system, with a minimum score of 
10 and a maximum score of 50.35 Helbok et al assessed 
the use of this score to predict severity in a small cohort 
(n=22) of adult patients with uncomplicated falciparum 
malaria35 and in adults with severe malaria (n=29)34 in 
Thailand. The score was not internally validated in both 
studies but the authors showed that higher scores were 
correlated with symptom severity and duration of hospi-
talisation. In 2006, the authors used a simplified version 
of the score—simplified MODS (sMODS); in a cohort of 
485 children in Gabon to predict the level of severity of 
the disease with respect to the amout of disability the chil-
dren suffered into categories: ability to walk unaided and 
ability to sit unaided.36 The authors obtained an AUC of 
0.92 (95% CI 0.89 to 0.95) in predicting inability to walk 
≥48 hours for children with sMODS ≥16 and an AUC of 
0.90 (95% CI 0.87 to 0.93) in predicting inability to sit 
unaided (table 4).
Grigg et al in 2018, used a multivariable logistic regres-
sion model to predict the severity of Plasmodium knowlesi 
malaria infection in a cohort of 481 participants in 
Malaysia. The authors showed that independent predic-
tors of disease severity using the WHO 2014 research 
criteria45 were: increasing age, abdominal pain, shortness 
of breath, increasing parasite count, schizont proportion 
>10% and serum bicarbonate levels <18 mmol. The model 
was not internally or externally validated (table 4).
DISCuSSIOn
In this review, we report on the various prognostic models 
and scores produced to predict complications, mortality 
and severity of malaria infection. We showed that there 
were 2 models produced to predict the risk of devel-
oping complications from malaria infection, 12 models 
that predict mortality from severe malaria in children, 
9 models that predict mortality from severe malaria 
in adults and 4 models that predict disease severity in 
malaria. Seventeen of these models were internally vali-
dated while only seven have been externally validated. 
There is no published evidence that any of these models 
are routinely used in clinical settings.
The models identified in this review that were used to 
predict mortality in children with severe malaria have 
similar clinical predictors. All the models had neuro-
logical dysfunction based on either the Glasgow coma 
score, impaired consciousness, altered mental status, 
convulsions, decerabration or coma as a predictor. Simi-
larly, in adults, all the models predicting mortality also 
had neurological dysfuction as a predictor. Microvas-
cular obstruction in capillaries of the brain due to direct 
sequestration of red blood cells infected with the malaria 
parasite could lead to tissue hypoxia.46 The effects of 
this sequestration and its sequelae in the brain can be 
directly visualised in both adults and children as reti-
nopathy.16 46–48 This leads to varied results with increased 
intracranial pressure more pronounced in children than 
in adults.46 With the increased oxygen demand associ-
ated with brain hypoxia and raised intracranial pressure, 
coma and brain dysfunction could therefore become an 
important predictor of mortality.
In children, half of the models predicting mortality had 
hypoglycaemia as a predictor.21–23 27 28 32 Hypoglycaemia 
is usually implicated as a complication of severe malaria 
infection. This association has been said to be multifacto-
rial.49 Proposed mechanisms for this association include: 
increased glucose use by the malaria parasites in the red 
blood cells, inhibition of gluconeogenesis by the cascade 
of cytokines released due to infection and prolonged star-
vation and fasting especially in severely ill children further 
compounds the problem.49 50 Considering that glucose is 
the primary source for organs like the brain which is likely 
suffering from the above highlighted effects of microvas-
cular obstruction and sequestration; depleted glucose 
sources could lead to neurological dysfuction including 
seizures, deepening comas and hence death. As above, 
any factor that significantly affects neurological dysfuc-
tion could be highly predictive of mortality or disease 
severity in patients.
Half of the models in children predicting mortality 
had respiratory distress (including deep breathing and 
subcostal indrawing) as a predictor.16 20 23 28 31 Mean-
while, six out of the nine models in adults had respira-
tory failure as a clinical predictor of mortality.19 24 26 41 
The incidence of respiratory distress in severe malaria 
is quite common as it occurs in about 40% of children 
with severe falciparum malaria and in 25% of adults.51 It 
results from acute respiratory distress syndrome (ARDS); 
metabolic acidosis; fluid overload possibly resulting from 
increased inflammatory related capillary permeability 
and endothelial damage8 51; and aspiration pneumonia 
which could lead to sepsis8—a common association with 
severe malaria. The high mortality rates (up to 87% in 
some cases) associated with respiratory failure like in 
ARDS52 could explain the predictive significance of respi-
ratory distress in predicting mortality in malaria infec-
tion. Respiratory failure usually leads to hypoxia and a 
high probability of acute mortality in patients.
Acidosis was also a prominent predictor of mortality in 
most of the models predicting mortality. It was present in 
three of the models predicting mortality in children28 30 32 
and five models predicting mortality in adults.17 18 26 29 41 
Acidosis usually results from underlying pathologies like 
respiratory distress, renal failure and shock. These three 
variables were also common variables in the models 
predicting mortality in both children and adults iden-
tified in this review. Renal failure expressed in these 
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Figure 2 Predictive factors of disease severity and mortality in malaria infection.
Table 5 Findings of review, research gaps and potential for future research
Findings of review Research gaps
Potential for future 
research Other possible avenues
Several models available to predict 
various outcomes in severe malaria.
Incorporation of produced 
models into artificial 
intelligence to help in the 
fast prediction of risks of 
adverse outcomes and 
suggestions of treatment 
and management 
modalities.
Variables consistent in predicting disease 
severity, mortality and complications 
include: neurological dysfunction, 
respiratory distress and acidosis.
Models that take into 
consideration these major 
variables.
Studies with robust designs.
Most models have high risk of bias due 
to lack of use of up- to- date methods of 
internal validation.
Models without risk of 
bias that use adequate 
statistical methods of 
internal validation.
Internal validation and wide 
external validation to help 
integrate models into daily 
clinical practice.
models either as acute renal failure, oligoanuria or esti-
mates of the kidney function using serum urea and creat-
inine17 19 24–26 30 32 41; is due to acute tubular necrosis that 
occurs in severe malaria infection as a direct result of 
microvascular obstruction of capillaries by infected red 
blood cells leading to the release of inflammatory cyto-
kines like TNF.53 Similarly, shock expressed either as a 
function of the systolic blood pressure or cold periph-
eries in three models in children21 31 32 and likewise in 
two models in adults19 41 could result from peripheral 
vasodilation which may usually occur concomitantly with 
sepsis and is a marker of a poor prognosis.8 54 55
From the above, factors that were predictive of disease 
severity and mortality seemed to be consistent among 
these studies. The factors that should therefore be consid-
ered by physicians when faced with a patient with malaria 
infection should include: neurological dysfunction (coma 
and seizures), acidosis, hypoglycaemia and respiratory 
distress (figure 2). These factors seem to be highly predic-
tive of mortality and disease severity in most of the articles 
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that were included in the review and should therefore be 
included in any future studies attempting to predict these 
outcomes in malaria (table 5).
We found evidence of external validation in only seven 
of the models identified in this study.18 20 24 31 32 External 
validation is an important component as it determines 
the generalisability of the model and its potential use 
in different geographical regions.56 As outlined above, 
most of the models have similar variables highlighting 
the fact that the predictors of complications, severity and 
mortality in malaria might be consistent across different 
settings. Emphasis could therefore be better placed in the 
validation of existing models and initiating their use in 
clinical settings to guide clinicians on prioritising patients 
and anticipating outcomes. Publication of the findings on 
the use of these models in clincal settings should also be 
encouraged to guide clinicians on which models work 
better in various settings.
After assessment of the risk of bias of the various models, 
18 of the studies contained models that used variables 
that could be readily available and hence were applicable 
in real- life settings. However, all the models had a high 
risk of bias. This was primarily due to the lack of internal 
validation in several of the studies or the lack of use of 
up- to- date methods of validation. Caution should there-
fore be used when interpreting and using the results from 
the articles.
This review has some limitations. The search included 
only articles that were published in English. This could 
potentially lead to the exclusion of studies and models 
that could otherwise have been included in the review.
COnCluSIOn
Models predicting severity and mortality of malaria infec-
tion identified in this review have similar predictors. 
Evidence is, however, lacking on the generalisability of 
most of these models due lack of external validation. 
Emphasis should therefore be placed on external valida-
tion of existing models and publication of the findings 
of their use in clinical settings to guide clinicians on 
management options depending on the priorities of their 
patients.
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